Email Signature for Pharmaceutical Companies

Pharmaceutical and life sciences companies treat the email signature as a compliance surface. The content is usually minimal: the employee's name, title, function, the legal entity, office address, and phone, followed by a confidentiality notice and the legal entity details each country requires. The reason for restraint is promotion law. In the United States, prescription drug advertising must present fair balance between benefits and risks under 21 CFR 202.1, and FDA applies the same standard to promotional labeling, so a signature banner or tagline that names a product or makes a claim about it can become promotional material that needs important safety information and review. Most companies therefore route any signature banner through medical, legal, and regulatory review, often called MLR, and keep field sales and medical science liaison signatures free of product claims. Corporate banners are typically limited to non-product topics such as careers, sustainability reports, or a corporate event. Companies operating in many countries also need language and entity details per market, and a companies typically document signature changes as part of their promotional review records.